China CAS:65928-58-7 Manufacturer

We are going to make every single effort for being excellent and excellent, and accelerate our ways for standing while in the rank of international top-grade and high-tech enterprises for CAS:65928-58-7, We welcome clients, enterprise associations and mates from all parts in the world to speak to us and search for cooperation for mutual positive aspects.
CAS:65928-58-7, We take measure at any expense to achieve essentially the most up-to-date equipment and approaches. The packing of nominated brand is our a further distinguishing feature. The products to assure years of trouble-free service has attracted a great deal customers. The solutions are obtainable in improved designs and richer assortment, they're created scientifically of purely raw supplies. It readily available in a variety of designs and specs for your selection. The most recent kinds are a great deal better than the preceding one particular and they are quite popular with lots of prospects.

Hot Products

  • Mifepristone

    Mifepristone

    Mifepristone has specifications of CP and IP. DMF and GMP approved.

    CAS:84371-65-3

  • Estradiol Hemihydrate

    Estradiol Hemihydrate

    Estradiol Hemihydrate has USP and EP specification. DMF available.

    CAS:50-28-2

  • Testosterone Undecanoate

    Testosterone Undecanoate

    Testosterone undecanoate has CP specification. TP available and DMF under filing.

    CAS:5949-44-0

  • Cbz-Valganciclovir

    Cbz-Valganciclovir

    Cbz-Valganciclovir,N-Carbobenzyloxy-L-valinyl-ganciclovir (cas# 194154-40-0) is a compound useful in organic synthesis.

    CAS:194154-40-0

  • 4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic acid

    4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic acid

    4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic acid is an intermediate of Dutasteride.

    CAS:103335-55-3

  • Flumethasone

    Flumethasone

    Flumethasone is a glucocorticoid, an anti-inflammatory. It can promptly decrease inflammation, exudation and itching is experienced after application.

    CAS:2135-17-3

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept